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Acute respiratory diseases (ARD) are the most common cause of morbidity and
lost time in military personnel just as they are in the civilian population. Very high
rates of infection occur during basic recruit training. The major causes of respira-
tory illness during this period have been adenovirus, types 4 and 7, influenza, Myco-
plasma pneumoniae, group A hemolytic streptococcus, and the meningococci. Ex-
cellent studies of acute respiratory disease (ARD), mostly at Fort Bragg, North
Carolina were made by the Commission on Acute Respiratory Diseases during
World War II which have been well summarized by Langmuir and Dingle (1). The
fine investigations carried out in naval recruits over a 10-yr period at the Great
Lakes Naval Training Station in Great Lakes, Illinois have also been published (2).
The major differences in the pattern of infections in recruits as compared with
college adults of the same age (3-5) have been the very high attack rates for all
respiratory pathogens in military personnel and the unusual activity ofadenoviruses
during basic training. In college adults only 1-4% of respiratory illnesses are due to
adenoviruses (3-7) whereas they constituted up to 60% of the causes of all acute
respiratory infection in some recruit camps in prevaccine days (8).
Since World War II enormous advances have been made in the control of specific
acute respiratory infections in recruits and other military personnel. Influenza vac-
cine has been improved and is in regular use in all three services with an effectiveness
'Presented at the Society of Medical Consultants to the Armed Forces, Nov. 10, 1974, Washington,
D.C. Papers on Mycoplasma pneumoniae infections by Dr. Floyd Denny and on acute respiratory
diseases in the U.S. Army and Air Force by Maj. Dennis Swanson and Col. William Howell, respectively,
were not available for publication in this series.
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ratio against strains contained in the vaccine of the order 70-90% (9). An oral, live
adenovirus vaccine containing types 4 and 7 has been prepared and routinely used in
the successful control of these infections in recruit populations (10, 11). A me-
ningococcal vaccine against types A and C has been developed at the Walter Reed
Army Institute of Research, its effectiveness has been demonstrated in military
personnel, and it now is routinely employed on entry into the service (12, 13).
Streptococcal infections have been controlled in some settings by use of long
acting penicillin administered on arrival in recruit training (2). Mycoplasma pneu-
moniae remains a major challenge to both civilian and military populations (15), al-
though trials of some vaccine preparations have proved promising (15, 16).
However, there is evidence that an inactivated vaccine may induce cell-mediated but
not humoral immunity in sero-negative individuals (17).
The purpose of this symposium is to review the current experiences of the three
services in the U.S. Armed Forces with acute respiratory illnesses, including the re-
cent experience in Viet Nam, to detail the advances made with adenovirus and me-
ningococcal vaccines, and to demonstrate the usefulness of serological surveys in
investigating respiratory infections in South American recruits. We are fortunate in
having some of the major developers ofthese vaccines with us as well as other distin-
guished investigators ofrespiratory disease in military personnel.
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